SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$499,914.00
Award Year:
2004
Program:
SBIR
Phase:
Phase II
Contract:
0422194
Award Id:
63394
Agency Tracking Number:
0320087
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
1818 Skokie Blvd. Suite 158, Northbrook, IL, 60062
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Brian Pfister
PI
(847) 498-9634
kmasuda@articular.com
Business Contact:
Brian Pfister
(847) 498-9634
bpfister@articular.com
Research Institution:
n/a
Abstract
This Small Business Innovation Research Phase II project is to develop scale-up production technology to produce engineered cartilage for drug discovery using a proprietary Alginate Recovered Chondrocyte (ARC) method. This method stimulates adult human cartilage cells to form a cartilaginous tissue with proper compositional and functional properties. ARC cartilage tissue is expected to offer a cost-effective alternative to current culture systems and expensive animal studies while utilizing human tissue. The commercial application of this project will be in the area of drug discovery for cartilage-related problems such as rheumatoid arthritis.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government